Results of an EORTC trial appearing in The Lancet Oncology show that adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk o ...
16 hours ago
Leading doctors warn that sepsis deaths will not be curbed without radical rethink of research strategy
Leading doctors today [Monday 20 April, 2015] warn that medical and public recognition of sepsis—thought to contribute to between a third and a half of all hospital deaths—must improve if the number of deaths from this ...
Apr 20, 2015